secwatch.observer — SEC 8-K summary
======================================

Issuer:     Calidi Biotherapeutics, Inc. (CLDI)
CIK:        0001855485
Form:       8-K
Filed at:   2024-04-01T23:59:59+00:00
Accession:  0001493152-24-012176
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Calidi Biotherapeutics amends terms of $3.5M convertible notes; reset conversion price and mandatory conversion triggers
--------------------------------------------------------------------------------

- First note of $2.0M and second note of $1.5M amended, conversion price reset after 180 days to 94% of 10-day VWAP.
- Mandatory conversion triggered if company raises >=$8M in registered offering or >=$2M from non-affiliate at >=150% initial conversion price.
- Company must file resale registration statement within 5 business days after 180 days from note issuance.
- Amendments effective March 28, 2024; notes originally issued March 8, 2024 in settlement of unasserted claim.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855485/000149315224012176/0001493152-24-012176-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855485/000149315224012176/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-012176

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer